Luciano Marraffini
Oprichter bij Eligo Bioscience SA
Profiel
Luciano Marraffini is the founder of Intellia Therapeutics, Inc. (founded in 2014) and Eligo Bioscience SA (founded in 2014).
He holds a doctorate degree from The University of Chicago.
Actieve functies van Luciano Marraffini
| Bedrijven | Functie | Begin |
|---|---|---|
Eligo Bioscience SA
 Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Oprichter | 01-05-2014 |
Eerdere bekende functies van Luciano Marraffini
| Bedrijven | Functie | Einde |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Oprichter | - |
Opleiding van Luciano Marraffini
| The University of Chicago | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Eligo Bioscience SA
Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Health Services |
